Get research updatesBipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.
Future Self: An Episodic Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder
This study is no longer accepting new participants.
In Boston
Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder
This study is no longer accepting new participants.
In Palo Alto
A Pan-PPAR Agonist Treatment for Bipolar Depression: A Proof of Concept Study
This study has finished and is no longer accepting participants.
In Boston
A Double-Blind Placebo-Controlled Trial of a Probiotic Supplement to Prevent Relapse and Improve the Clinical Course After Hospitalization for Bipolar Depression
This study is no longer accepting new participants.
In TowsonAn Open-Label Pilot Study Examining the Feasibility, Safety, and Effectiveness of Psilocybin Therapy for Depression in Bipolar II Disorder
This study is no longer accepting new participants.
In San FranciscoSequential Multiple Assignment Randomized Trial for Bipolar Depression
This study is no longer accepting new participants.
Multiple locations, including BirminghamA Phase 2 Open-label Study of the Effect of Adjunctively Administered ABX-002 in Adults With Bipolar Disorder Experiencing an Episode of Depression
This study is no longer accepting new participants.
Multiple locations, including Walnut CreekResearchers are studying ABBV-932, tracking side effects to assess long-term safety and tolerability in people with bipolarity type I or II.
This study is no longer accepting new participants.
Multiple locations, including PhoenixThis study assessed depression symptoms.
This study has finished and is no longer accepting participants.
In BostonCognitive Outcomes and Response/Remission Efficacy of Convulsive Therapies for Bipolar Depression: the CORRECT-BD Trial
This study has finished and is no longer accepting participants.
Multiple locations, including VancouverA Pilot, Open-label, 8-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Minocycline for the Treatment of Bipolar Depression
This study has finished and is no longer accepting participants.
In TorontoRepeated Ketamine Infusions for Treatment-Resistant Bipolar Disorder: A Randomized, Double-blind, Midazolam-controlled, Phase II Clinical Trial
This study has finished and is no longer accepting participants.
Multiple locations, including TorontoWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.